Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Assets Average (2016 - 2025)

Historic Assets Average for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $2.5 billion.

  • Haemonetics' Assets Average fell 244.14% to $2.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 billion, marking a year-over-year decrease of 244.14%. This contributed to the annual value of $2.3 billion for FY2025, which is 1249.57% up from last year.
  • As of Q4 2025, Haemonetics' Assets Average stood at $2.5 billion, which was down 244.14% from $2.5 billion recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Assets Average ranged from a high of $2.5 billion in Q3 2024 and a low of $1.6 billion during Q2 2021
  • For the 5-year period, Haemonetics' Assets Average averaged around $2.1 billion, with its median value being $2.0 billion (2023).
  • In the last 5 years, Haemonetics' Assets Average surged by 3384.19% in 2021 and then crashed by 319.67% in 2025.
  • Over the past 5 years, Haemonetics' Assets Average (Quarter) stood at $1.8 billion in 2021, then increased by 4.1% to $1.9 billion in 2022, then increased by 12.52% to $2.1 billion in 2023, then increased by 20.06% to $2.5 billion in 2024, then dropped by 2.44% to $2.5 billion in 2025.
  • Its Assets Average stands at $2.5 billion for Q4 2025, versus $2.5 billion for Q3 2025 and $2.5 billion for Q2 2025.